New developments in the adrenergic pharmacology of normal and glaucomatous eyes.
D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D003986:Dibenzocycloheptenes / Q000494:pharmacology / Q000627:therapeutic use*; D005901:Glaucoma / Q000188:drug therapy* / Q000266:history / Q000503:physiopathology; D000882:Haplorhini; D006732:Horner Syndrome / Q000473:pathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use*; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000378:metabolism / Q000502:physiology*
D002395:Catecholamines; D003986:Dibenzocycloheptenes; D009638:Norepinephrine